Ozampic 4mg/3ml

**Ozempic 4mg/3ml – GLP-1 Weight Loss Peptide (Semaglutide)**

**Overview:**
Ozempic (Semaglutide) is a GLP-1 receptor agonist originally developed for Type 2 diabetes but now widely used off-label for weight loss and appetite suppression. At 4mg/3ml, this formulation delivers stable metabolic control and fat-burning potential.

**Mechanism:**
Mimics the GLP-1 hormone to regulate insulin, slow gastric emptying, and suppress appetite. Leads to reduced calorie intake and enhanced satiety.

**Benefits:**
– Dramatic appetite suppression
– Long-term sustainable fat loss
– Blood sugar regulation
– Improved metabolic markers

**Dosing Protocol:**
– Start: 0.25–0.5mg once weekly
– Gradually increase to 1mg–2mg weekly
– Inject subcutaneously in abdomen or thigh

**Use Cycle:**
Ideal for long-term fat loss, especially in individuals with insulin resistance or obesity.

**Side Effects:**
– Nausea (temporary)
– Mild GI discomfort
– Headaches or fatigue

**Storage:**
Refrigerate. Do not freeze. Protect from light.

**Disclaimer:**
For research use only. Medical supervision recommended.